Fludeoxyglucose F18
NDC 60215-411, Fludeoxyglucose F18, injection, from The University of Texas MD Anderson Cancer Center.
- Product NDC
- 60215-411
- Status
- Listed
- Labeler
- The University of Texas MD Anderson Cancer Center
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203246
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60215-411 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLUDEOXYGLUCOSE F-18300 mCi/mL
Pharmacologic classes
Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60215-411-30 | 60215041130 | 27 mL in 1 VIAL, GLASS (60215-411-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/43954e40-bb95-4275-92ab-96211b7de907
Use it
Look up 60215-411 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60215-411 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60215-411. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.